 |
Top 11 medical and healthcare startups in Barcelona
Last updated: May 07, 2024 |
1
Funding: $180.8M
Impress is a developer of orthodontic technology that offers invisible aligners.
Impress is a developer of orthodontic technology that offers invisible aligners.
2
Funding: $143.9M
Minoryx Therapeutics offers pharmacological chaperones, which are small molecule drugs used for the treatment of genetic diseases.
Minoryx Therapeutics offers pharmacological chaperones, which are small molecule drugs used for the treatment of genetic diseases.
3
Funding: $58.8M
Splice Bio is a biotech company developing gene therapies based on a platform that could bypass the cargo capacity of adeno-associated vectors (AAVs).
Splice Bio is a biotech company developing gene therapies based on a platform that could bypass the cargo capacity of adeno-associated vectors (AAVs).
4
Funding: €44.1M
Koa Health is a digital wellbeing and therapeutics solutions combine the latest clinical research and breakthrough technologies.
Koa Health is a digital wellbeing and therapeutics solutions combine the latest clinical research and breakthrough technologies.
5
Funding: €23.8M
Top Doctors is an online platform for identifying, interacting and booking e-consultations with medical specialists in private healthcare.
Top Doctors is an online platform for identifying, interacting and booking e-consultations with medical specialists in private healthcare.
6
Funding: $15.8M
The most advanced and accurate sypmtom checker. The first artificial intelligent system clinically validated that is transforming healthcare for everyone.
The most advanced and accurate sypmtom checker. The first artificial intelligent system clinically validated that is transforming healthcare for everyone.
7
Funding: €13.2M
Virtual Reality is the easiest and simplest way to offer best practices to anxiety patients, and at Psious, we work to make it accessible to mental health professionals. VR allows the patient to interact with environments in between in vivo and imaginal exposure, improving the flow and outcomes of exposure therapy.
Virtual Reality is the easiest and simplest way to offer best practices to anxiety patients, and at Psious, we work to make it accessible to mental health professionals. VR allows the patient to interact with environments in between in vivo and imaginal exposure, improving the flow and outcomes of exposure therapy.
9
Funding: $11.6M
Devicare has developed Lit-Control - the most advanced, comprehensive and effective medical treatment for Kidney Stones. Lit-Control is a family of four innovative medical foods that have been formulated to treat and manage the nutritional needs of patients with each of the four major groups of Kidney Stones (i.e. calcium, uric acid, infectious and cytine stones). And in combination with these medical foods, Lit-Control also incorporates a ground-breaking digital therapeutic to ease the follow-up of these patients.
Devicare has developed Lit-Control - the most advanced, comprehensive and effective medical treatment for Kidney Stones. Lit-Control is a family of four innovative medical foods that have been formulated to treat and manage the nutritional needs of patients with each of the four major groups of Kidney Stones (i.e. calcium, uric acid, infectious and cytine stones). And in combination with these medical foods, Lit-Control also incorporates a ground-breaking digital therapeutic to ease the follow-up of these patients.
10
Funding: €10.1M
Elma aims to provide access to healthcare anytime, anywhere and for anyone.
Elma aims to provide access to healthcare anytime, anywhere and for anyone.
11
Funding: €7.7M
MediQuo develops 24-hour, 7-day-a-week medical chat application that gives doctors and health professionals the ability to manage online appointments, both for their own patients as well as for the users of the app.
MediQuo develops 24-hour, 7-day-a-week medical chat application that gives doctors and health professionals the ability to manage online appointments, both for their own patients as well as for the users of the app.